Gland Pharma’s poor show in FY23 has shaken investor confidence. Can it reclaim lost ground?
Gland Pharma's plant at Pashamylaram, Telangana; image credit: companySynopsisGiven the consistent disappointments on the earnings front, investors are starting to worry if there is a…